{"organizations": [], "uuid": "19fdc6ea5de3ca8df0ce73bd45774067d2c6050f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-indivior-asserts-new-patent-agains/brief-indivior-asserts-new-patent-against-anda-filers-idUSFWN1PY055", "country": "US", "domain_rank": 408, "title": "BRIEF-Indivior Asserts New Patent Against ANDA-Filers", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.147, "site_type": "news", "published": "2018-02-08T15:13:00.000+02:00", "replies_count": 0, "uuid": "19fdc6ea5de3ca8df0ce73bd45774067d2c6050f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-indivior-asserts-new-patent-agains/brief-indivior-asserts-new-patent-against-anda-filers-idUSFWN1PY055", "ord_in_thread": 0, "title": "BRIEF-Indivior Asserts New Patent Against ANDA-Filers", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "actavis", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "teva", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Indivior Plc:\n* INDIVIOR ASSERTS NEW PATENT AGAINST ANDA-FILERS * U.S. UNIT FILED PATENT LAWSUITS AGAINST DR. REDDY‘S, ACTAVIS, PAR, ALVOGEN AND TEVA FOR INFRINGEMENT OF UNITED STATES PATENT NO. 9,855,221\n* ‍PATENT RELATING TO THEIR RESPECTIVE PROPOSED GENERIC VERSIONS OF COMPANY‘S SUBOXONE® (BUPRENORPHINE AND NALOXONE) SUBLINGUAL FILM PRODUCT​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T15:13:00.000+02:00", "crawled": "2018-02-09T16:41:31.027+02:00", "highlightTitle": ""}